Cross-Coupling Reactions Leading to Chiral Heterocyclic Scaffolds for Drug Development and Manufacturing
Cross-Coupling Reactions Leading to Chiral Heterocyclic Scaffolds for Drug Development and Manufacturing
批准号:
536415-2018
负责人:
OrellanaGarcia, JosueArturo
金额:
$4.05万
依托单位:
依托单位国家:
加拿大
项目类别:
Collaborative Research and Development Grants
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-01-01 至 2021-12-31
中文摘要
杂环化合物是具有至少一个非碳原子的环状分子,由于其良好的物理和化学性质而广泛应用于药物的发现和开发。吡啶是FDA批准的药物中应用最广泛的芳香族杂环化合物,对其及其衍生物的制备方法有持续的需求。不幸的是,大多数这样做的方法都采用了苛刻的反应条件,因此没有得到广泛应用。
英文摘要
Heterocycles, cyclic molecules with at least one non-carbon atom, are widely used in drug discovery and development due to their favourable physical and chemical properties. Pyridines are the most widely used aromatic heterocycle in FDA approved drugs and there is a continued demand for methods to prepare them and their derivatives. Unfortunately, the majority of methods to do this employ harsh reaction conditions and are therefore not widely useful.
We have devised a conceptually new approach to make pyridine derivatives using exceptionally mild conditions that tolerate a wide range of functional groups. These reactions also provide immediate access to small molecules that possess 'drug-like' qualities and that are hard to make by other means. Finally, our methods are catalytic and therefore will contribute to the reduction of the environmental costs of drug discovery and development. As a result, the proposed research will have a direct impact on the search for new therapeutic agents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cross-Coupling Reactions Leading to Chiral Heterocyclic Scaffolds for Drug Development and Manufacturing
-
批准号:536415-2018
-
项目类别:Collaborative Research and Development Grants
-
资助金额:$4.05万
-
财政年份:2021
-
负责人:OrellanaGarcia, JosueArturo
-
依托单位:
国内基金
海外基金
基于外泌体TRPV4-Nox4 coupling途径探讨缺氧微环境调控鼻咽癌转移侵袭和血管新生的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2021
-
负责人:张鹏
-
依托单位: